Statin Intensity and Clinical Outcome in Patients with Stable Coronary Artery Disease and Very Low LDL-Cholesterol.

Statin Intensity and Clinical Outcome in Patients with Stable Coronary Artery Disease and Very Low LDL-Cholesterol.

Although intensive statin therapy is recommended for high risk patients, evidence of its benefit in patients with stable coronary artery disease (CAD) and very low low-density lipoprotein-cholesterol (LDL-C) has been very rare. In this study, we investigated whether higher statin intensity reduces c...

Full description

Bibliographic Details
Main Authors:	Soo Youn Lee, Seung-Jin Oh, Eung Ju Kim, Chi-Yoon Oum, Sung Hwan Park, Jaewon Oh, Jung-Sun Kim, Byeong-Keuk Kim, Sungha Park, Hyuk-Jae Chang, Geu-Ru Hong, Young-Guk Ko, Seok-Min Kang, Donghoon Choi, Jong-Won Ha, Myeong-Ki Hong, Yangsoo Jang, Namsik Chung, Sang-Hak Lee
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5100958?pdf=render

Similar Items

Effect of fenofibrate in 1113 patients at low-density lipoprotein cholesterol goal but high triglyceride levels: Real-world results and factors associated with triglyceride reduction.
by: Yeongmin Woo, et al.
Published: (2018-01-01)

Efficacy of Statin Treatment According to Baseline Renal Function in Korean Patients with Acute Myocardial Infarction Not Requiring Dialysis Undergoing Newer-Generation Drug-Eluting Stent Implantation
by: Yong Hoon Kim, et al.
Published: (2021-08-01)

Differential influences of LDL cholesterol on functional outcomes after intravenous thrombolysis according to prestroke statin use
by: You-Ri Kang, et al.
Published: (2022-09-01)

Effect of moderate-intensity statin with ezetimibe combination vs. high-intensity statin therapy according to sex in patients with atherosclerosis
by: Byung Gyu Kim, et al.
Published: (2023-11-01)

Comparative effect of statin intensity between prediabetes and type 2 diabetes mellitus after implanting newer-generation drug-eluting stents in Korean acute myocardial infarction patients: a retrospective observational study
by: Yong Hoon Kim, et al.
Published: (2021-08-01)

Macrophage polarization and acceleration of atherosclerotic plaques in a swine model.
by: Seul-Gee Lee, et al.
Published: (2018-01-01)

Long‐Term Clinical Outcomes of Late Stent Malapposition Detected by Optical Coherence Tomography After Drug‐Eluting Stent Implantation
by: Eui Im, et al.
Published: (2019-04-01)

Severe Acute Stent Malapposition After Drug‐Eluting Stent Implantation: Effects on Long‐Term Clinical Outcomes
by: Seung‐Yul Lee, et al.
Published: (2019-07-01)

Temporal Trends of Antithrombotic Therapy in Patients With Acute Myocardial Infarction and Atrial Fibrillation: Insight From the KAMIR-NIH Registry
by: Oh-Hyun Lee, et al.
Published: (2021-11-01)

Association of Morning Hypertension Subtype With Vascular Target Organ Damage and Central Hemodynamics
by: Jaewon Oh, et al.
Published: (2017-02-01)

Impact of preprocedural coronary flow grade on duration of dual antiplatelet therapy in acute myocardial infarction
by: Yong Hoon Kim, et al.
Published: (2021-06-01)

Escalation of liPid-lOwering therapy in patientS wiTh vascular disease receiving HIGH-intensity statins: the retrospective POST-HIGH study
by: Jaehyung Ha, et al.
Published: (2021-04-01)

Age‐Dependent Effect of Ticagrelor Monotherapy Versus Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events: A Post Hoc Analysis of the TICO Randomized Trial
by: Byung Gyu Kim, et al.
Published: (2021-12-01)

Differences in left ventricular functional adaptation to arterial stiffness and neurohormonal activation in patients with hypertension: a study with two-dimensional layer-specific speckle tracking echocardiography
by: Darae Kim, et al.
Published: (2017-11-01)

LDL Cholesterol, Statins And PCSK 9 Inhibitors
by: Sanjiv Gupta
Published: (2015-09-01)

Efficacy and safety of moderate-intensity statin with ezetimibe combination therapy in patients after percutaneous coronary intervention: a post-hoc analysis of the RACING trialResearch in context
by: Jong-Il Park, et al.
Published: (2023-04-01)

Corrigendum: Safety and efficacy of contemporary drug-eluting stents in patients with ST-segment elevation myocardial infarction and a high ischemic risk
by: Oh-Hyun Lee, et al.
Published: (2022-08-01)

Safety and Efficacy of Contemporary Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction and a High Ischemic Risk
by: Oh-Hyun Lee, et al.
Published: (2022-05-01)

The Effect of FLT1 Variant on Long-Term Cardiovascular Outcomes: Validation of a Locus Identified in a Previous Genome-Wide Association Study.
by: Chan Joo Lee, et al.
Published: (2016-01-01)

Clinical implication of ticagrelor monotherapy in patients with small vessel coronary artery disease: results from the TICO randomized trial
by: Jae Young Cho, et al.
Published: (2023-08-01)

Body mass index affecting ticagrelor monotherapy vs. ticagrelor with aspirin in patients with acute coronary syndrome: A pre-specified sub-analysis of the TICO randomized trial
by: Byung Gyu Kim, et al.
Published: (2023-03-01)

Assessment of fractional flow reserve in intermediate coronary stenosis using optical coherence tomography-based machine learning
by: Jung-Joon Cha, et al.
Published: (2023-01-01)

Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR.
by: Yong Hoon Kim, et al.
Published: (2018-01-01)

Optical coherence tomography-based machine learning for predicting fractional flow reserve in intermediate coronary stenosis: a feasibility study
by: Jung-Joon Cha, et al.
Published: (2020-11-01)

Outcomes of Different Reperfusion Strategies of Multivessel Disease Undergoing Newer-Generation Drug-Eluting Stent Implantation in Patients with Non-ST-Elevation Myocardial Infarction and Chronic Kidney Disease
by: Yong Hoon Kim, et al.
Published: (2021-10-01)

Comparison of First- and Second-Generation Drug-Eluting Stents in Patients with ST-Segment Elevation Myocardial Infarction Based on Pre-Percutaneous Coronary Intervention Thrombolysis in Myocardial Infarction Flow Grade
by: Yong Hoon Kim, et al.
Published: (2021-01-01)

Beta-Blocker and Renin–Angiotensin System Inhibitor Combination Therapy in Patients with Acute Myocardial Infarction and Prediabetes or Diabetes Who Underwent Successful Implantation of Newer-Generation Drug-Eluting Stents: A Retrospective Observational Registry Study
by: Yong Hoon Kim, et al.
Published: (2020-10-01)

Comparison of clinical outcomes between angiotensin-converting-enzyme inhibitors and ARBs in patients with acute myocardial infarction with dyslipidemia after a successful stent implantation
by: Yong Hoon Kim, et al.
Published: (2020-01-01)

Effects of stent generation on clinical outcomes after acute myocardial infarction compared between prediabetes and diabetes patients
by: Yong Hoon Kim, et al.
Published: (2021-04-01)

Outcomes between prediabetes and type 2 diabetes mellitus in older adults with acute myocardial infarction in the era of newer-generation drug-eluting stents: a retrospective observational study
by: Yong Hoon Kim, et al.
Published: (2021-11-01)

Optimal duration of DAPT after second-generation drug-eluting stent in acute coronary syndrome.
by: Ji-Yong Jang, et al.
Published: (2018-01-01)

Long-Term Beta-Blocker Therapy in Patients With Stable Coronary Artery Disease After Percutaneous Coronary Intervention
by: Seung-Jun Lee, et al.
Published: (2022-05-01)

Prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients with diabetes mellitus: A nationwide retrospective cohort study
by: Seung-Jun Lee, et al.
Published: (2022-08-01)

Stent expansion evaluated by optical coherence tomography and subsequent outcomes
by: Bom Lee, et al.
Published: (2023-03-01)

The role of statins in clinical medicine -LDL - cholesterol lowering and beyond
by: Swiss Medical Weekly
Published: (2006-01-01)

Insulin Protects Cardiac Myocytes from Doxorubicin Toxicity by Sp1-Mediated Transactivation of Survivin.
by: Beom Seob Lee, et al.
Published: (2015-01-01)

Ticagrelor vs. Clopidogrel in Acute Coronary Syndrome Patients With Chronic Kidney Disease After New-Generation Drug-Eluting Stent Implantation
by: Ji Woong Roh, et al.
Published: (2022-01-01)

Long-Term Clinical Outcomes Between Biodegradable and Durable Polymer Drug-Eluting Stents: A Nationwide Cohort Study
by: Seung-Jun Lee, et al.
Published: (2022-04-01)

Relation Between Blood Pressure and Clinical Outcome in Hypertensive Subjects With Previous Stroke
by: Chan Joo Lee, et al.
Published: (2017-12-01)

Ischemic and Bleeding Events of Ticagrelor Monotherapy in Korean Patients With and Without Diabetes Mellitus: Insights From the TICO Trial
by: Kyeong Ho Yun, et al.
Published: (2021-01-01)